High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: A report from the children's oncology group

British Journal of Haematology

Volumn 162, Issue 5, 2013, Pages 670-677

  Ho, Phoenix A ^a,b,c   Alonzo, Todd A ^c,d   Gerbing, Robert B ^c   Pollard, Jessica A ^a,b,c   Hirsch, Betsy ^c,e   Raimondi, Susana C ^c,f   Cooper, Todd ^c,g   Gamis, Alan S ^c,h   Meshinchi, Soheil ^a,b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^h CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Acute myeloid leukaemia; EVI1; MLL; Paediatric cancer

Indexed keywords

MESSENGER RNA; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER PROGNOSIS; CHILD; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; EVI1 GENE; FEMALE; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MLL GENE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SURVIVAL PREDICTION;

ACUTE MYELOID LEUKAEMIA; EVI1; MLL; PAEDIATRIC CANCER;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PILOT PROJECTS; PROGNOSIS; PROTO-ONCOGENES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84881663530     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12444     Document Type: Article

References (29)

1. Asmann, Y.W., Hossain, A., Necela, B.M., Middha, S., Kalari, K.R., Sun, Z., Chai, H.S., Williamson, D.W., Radisky, D., Schroth, G.P., Kocher, J.P., Perez, E.A. & Thompson, E.A. (2011) A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Research, 39, e100.
2. Balgobind, B.V., Raimondi, S.C., Harbott, J., Zimmermann, M., Alonzo, T.A., Auvrignon, A., Beverloo, H.B., Chang, M., Creutzig, U., Dworzak, M.N., Forestier, E., Gibson, B., Hasle, H., Harrison, C.J., Heerema, N.A., Kaspers, G.J., Leszl, A., Litvinko, N., Nigro, L.L., Morimoto, A., Perot, C., Pieters, R., Reinhardt, D., Rubnitz, J.E., Smith, F.O., Stary, J., Stasevich, I., Strehl, S., Taga, T., Tomizawa, D., Webb, D., Zemanova, Z., Zwaan, C.M. & van den Heuvel-Eibrink, M.M. (2009) Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood, 114, 2489-2496.
3. Balgobind, B.V., Lugthart, S., Hollink, I.H., Arentsen-Peters, S.T., van Wering, E.R., de Graaf, S.S., Reinhardt, D., Creutzig, U., Kaspers, G.J., de Bont, E.S., Stary, J., Trka, J., Zimmermann, M., Beverloo, H.B., Pieters, R., Delwel, R., Zwaan, C.M. & van den Heuvel-Eibrink, M.M. (2010) EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. Leukemia, 24, 942-949.
4. Barnard, D.R., Alonzo, T.A., Gerbing, R.B., Lange, B. & Woods, W.G. (2007) Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: a report from the Children's Oncology Group. Pediatric Blood & Cancer, 49, 17-22.
5. Bernt, K.M. & Armstrong, S.A. (2011) Targeting epigenetic programs in MLL-rearranged leukemias. Hematology/The Education Program of the American Society of Hematology, 2011, 354-360.
6. Brown, P., McIntyre, E., Rau, R., Meshinchi, S., Lacayo, N., Dahl, G., Alonzo, T.A., Chang, M., Arceci, R.J. & Small, D. (2007) The incidence and clinical significance of nucleophosmin mutations in childhood AML. Blood, 110, 979-985.
7. Cattaneo, F. & Nucifora, G. (2008) EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression. Journal of Cellular Biochemistry, 105, 344-352.
8. Cooper, T.M., Franklin, J., Gerbing, R.B., Alonzo, T.A., Hurwitz, C., Raimondi, S.C., Hirsch, B., Smith, F.O., Mathew, P., Arceci, R.J., Feusner, J., Iannone, R., Lavey, R.S., Meshinchi, S. & Gamis, A. (2012) AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. Cancer, 118, 761-769.
9. Ge, H., Liu, K., Juan, T., Fang, F., Newman, M. & Hoeck, W. (2011) FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics, 27, 1922-1928.
10. Groschel, S., Schlenk, R.F., Engelmann, J., Rockova, V., Teleanu, V., Kühn, M.W., Eiwen, K., Erpelinck, C., Havermans, M., Lübbert, M., Germing, U., Schmidt-Wolf, I.G., Beverloo, H.B., Schuurhuis, G.J., Ossenkoppele, G.J., Schlegelberger, B., Verdonck, L.F., Vellenga, E., Verhoef, G., Vandenberghe, P., Pabst, T., Bargetzi, M., Krauter, J., Ganser, A., Valk, P.J., Löwenberg, B., Döhner, K., Döhner, H. & Delwel, R. (2013) Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian acute myeloid leukemia study group and the Dutch-Belgian-Swiss HOVON/SAKK cooperative group. Journal of Clinical Oncology, 31, 95-103.
11. Gröschel, S., Lugthart, S., Schlenk, R.F., Valk, P.J., Eiwen, K., Goudswaard, C., van Putten, W.J., Kayser, S., Verdonck, L.F., Lübbert, M., Ossenkoppele, G.J., Germing, U., Schmidt-Wolf, I., Schlegelberger, B., Krauter, J., Ganser, A., Döhner, H., Löwenberg, B., Döhner, K. & Delwel, R. (2010) High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. Journal of Clinical Oncology, 28, 2101-2107.
12. Haferlach, C., Bacher, U., Grossmann, V., Schindela, S., Zenger, M., Kohlmann, A., Kern, W., Haferlach, T. & Schnittger, S. (2012) Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Genes, Chromosomes & Cancer, 51, 1079-1085.
13. Harrison, C.J., Hills, R.K., Moorman, A.V., Grimwade, D.J., Hann, I., Webb, D.K., Wheatley, K., de Graaf, S.S., van den Berg, E., Burnett, A.K. & Gibson, B.E. (2010) Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. Journal of Clinical Oncology, 28, 2674-2681.
14. Ho, P.A., Alonzo, T.A., Gerbing, R.B., Pollard, J., Stirewalt, D.L., Hurwitz, C., Heerema, N.A., Hirsch, B., Raimondi, S.C., Lange, B., Franklin, J.L., Radich, J.P. & Meshinchi, S. (2009) Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the children's oncology group. Blood, 113, 6558-6566.
15. Ho, P.A., Kuhn, J., Gerbing, R.B., Pollard, J.A., Zeng, R., Miller, K.L., Heerema, N.A., Raimondi, S.C., Hirsch, B.A., Franklin, J.L., Lange, B., Gamis, A.S., Alonzo, T.A. & Meshinchi, S. (2011a) The WT1 synonymous SNP rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric AML: a report from the Children's Oncology Group. Journal of Clinical Oncology, 29, 704-711.
16. Ho, P.A., Kutny, M.A., Alonzo, T.A., Gerbing, R.B., Joaquin, J., Raimondi, S.C., Gamis, A.S. & Meshinchi, S. (2011b) Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group. Pediatric Blood & Cancer, 57, 204-209.
17. Hoyt, P.R., Bartholomew, C., Davis, A.J., Yutzey, K., Garner, L.W., Potter, S.S., Ihle, J.N. & Mucenski, M.L. (1997) The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mechanisms of Development, 65, 55-70.
18. Kim, D. & Salzberg, S.L. (2011) TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biology, 12, R72.
19. Laricchia-Robbio, L. & Nucifora, G. (2008) Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells, Molecules & Diseases, 40, 141-147.
20. Lugthart, S., van Drunen, E., van Norden, Y., van Hoven, A., Erpelinck, C.A., Valk, P.J., Beverloo, H.B., Löwenberg, B. & Delwel, R. (2008) High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood, 111, 4329-4337.
21. Martinelli, G., Ottaviani, E., Buonamici, S., Isidori, A., Borsaru, G., Visani, G., Piccaluga, P.P., Malagola, M., Testoni, N., Rondoni, M., Nucifora, G., Tura, S. & Baccarani, M. (2003) Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. Haematologica, 88, 1221-1228.
22. Mawad, R. & Estey, E.H. (2012) Acute myeloid leukemia with normal cytogenetics. Current Oncology Reports, 14, 359-368.
23. McPherson, A., Hormozdiari, F., Zayed, A., Giuliany, R., Ha, G., Sun, M.G., Griffith, M., Heravi Moussavi, A., Senz, J., Melnyk, N., Pacheco, M., Marra, M.A., Hirst, M., Nielsen, T.O., Sahinalp, S.C., Huntsman, D. & Shah, S.P. (2011) deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. Public Library of Science International Society for Computational Biology, 7, e1001138.
24. Meshinchi, S., Alonzo, T.A., Stirewalt, D.L., Zwaan, M., Zimmerman, M., Reinhardt, D., Kaspers, G.J., Heerema, N.A., Gerbing, R., Lange, B.J. & Radich, J.P. (2006) Clinical implications of FLT3 mutations in pediatric AML. Blood, 108, 3654-3661.
25. Morishita, K., Parker, D.S., Mucenski, M.L., Jenkins, N.A., Copeland, N.G. & Ihle, J.N. (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell, 54, 831-840.
26. Saito, Y., Nakahata, S., Yamakawa, N., Kaneda, K., Ichihara, E., Suekane, A. & Morishita, K. (2011) CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression. Leukemia, 25, 921-931.
27. Schmittgen, T.D. & Livak, K.J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols, 3, 1101-1108.
28. Senyuk, V., Premanand, K., Xu, P., Qian, Z. & Nucifora, G. (2011) The oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA. PLoS ONE, 6, e20793.
29. Sitailo, S., Sood, R., Barton, K. & Nucifora, G. (1999) Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. Leukemia, 13, 1639-1645.